Researchers have developed technologies that allow damaged proteins to be shredded or healthy ones installed. This may ...

T-cell engagers are antibody-based therapeutics that can reprogram T cells for antigen-specific elimination of target cells.

Chemotherapy reshapes gut bacteria in ways that send powerful signals throughout the body. These signals reprogram immune cells, making organs like the liver more resistant to metastatic cancer.

The conversation around longevity is shifting. For decades, the goal was simple: live longer. But as medicine advances and ...

The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients. With ...

Researchers have uncovered a stealthy way pancreatic cancer disarms the immune system, using tiny molecular messengers to ...

Precise methods for shredding or repairing and replacing specific cancer-causing proteins in a malignant cell, developed at ...

New insights into a sophisticated process that protects sperm cells has revealed a mechanism, similar to an immune system, thwarts genetic chaos during the earliest stages of their development.

Bristol Myers Squibb BMY and GSK PLC GSK are among the largest global biopharma companies with broad and diverse portfolios.

Explore the potential of bacteriophages as a breakthrough therapy against bacterial infections amidst rising antibiotic ...

Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a bold new front. With $1 million in funding from Breakthrough T1D, the ...